Highlander Capital Management’s Quest Diagnostics DGX Stock Holding History

Highlander Capital Management’s Portfolio DGX Stock Details DGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-700	Closed	-$56K	–	607
2020 Q1	$56K	Buy	+700	New	+$72.5K	0.04%	258
2015 Q1	–	Sell	-2,300	Closed	-$154K	–	846
2014 Q4	$154K	Sell	2,300 -4,675	-67%	-$295K	0.13%	183
2014 Q3	$423K	Sell	6,975 -200	-3%	-$12.3K	0.4%	66
2014 Q2	$421K	Hold	7,175	–	–	0.38%	69
2014 Q1	$416K	Buy	7,175 +3,500	+95%	+$188K	0.39%	66
2013 Q4	$197K	Hold	3,675	–	–	0.19%	146
2013 Q3	$227K	Hold	3,675	–	–	0.23%	121
2013 Q2	$223K	Buy	+3,675	New	+$219K	0.24%	117

Other funds holding DGX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

FMI

Fiduciary Management Inc Milwaukee, Wisconsin $7.03B AUM 11.68% 1-Year Est. Return

DSA

Davis Selected Advisers Tucson, Arizona $23.3B AUM 26.95% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Highlander Capital Management's DGX Position: Q2 2020 in Review

Highlander Capital Management sold out of Quest Diagnostics (DGX) in Q2 2020, closing a stake of 700 shares — an estimated $56K sold.

Highlander Capital Management first reported a position in DGX in Q2 2013 and held it in 8 quarters. The position peaked at $423K in Q3 2014. 749 funds tracked by Wall St. Rank hold DGX as of Q2 2020.

Highlander Capital Management reported no remaining Quest Diagnostics position as of Q2 2020 after selling out during the quarter.
Highlander Capital Management sold 700 Quest Diagnostics shares in Q2 2020, an estimated $56K.
Highlander Capital Management first reported a position in Quest Diagnostics in Q2 2013 and held it in 8 quarters.
Highlander Capital Management's Quest Diagnostics position peaked at $423K in Q3 2014.
749 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2020.

Based on Highlander Capital Management's 13F filing for Q2 2020, filed 17 Aug 2020.